LEP and chronic kidney disease: Experimental data and clinical studies in CKD indicate that leptin in high concentrations can produce endothelial dysfunction by modifying the f-actin cytoskeleton through a mechanism involving the protein kinase B/glycogen synthase kinase β (AKT/GSK3β), nitric oxide, and β-catenin pathway [64,65].